Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • NPPA fixes prices of...

    NPPA fixes prices of 50 FDC drugs and revises 4 others

    Written by Geeta Sharma Sharma Published On 2016-05-01T10:38:57+05:30  |  Updated On 1 May 2016 10:38 AM IST
    NPPA fixes prices of 50 FDC drugs and revises 4 others
    New Delhi:Prices of 50 Drugs have been fixed, while 4 others revised, by the National Pharmaceutical Pricing Authority (NPPA). This is part of the new drug pricing control order, notified on March 14, which effectively brings 200 more drug formulations under regulation.

    40 other drugs are to be priced by the NPPA in the coming weeks, for which the NPPA has asked requisite information be provided to it, by the companies. 92 applications for evaluation are up with the NPPA for retail price fixation of new fixed dose combinations (FDC's), the authority informed the parliament on Friday, reports
    Business Standard
    .

    The NPPA has issued directions to all pharmaceutical companies with pending FDC applications to submit signed declarations by designated authority that the FDC's put up by them have not been banned by the drug control authorities.

    "At present, 92 applications for retail price fixation of new FDCs are under examination at NPPA," Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir said in a written reply to the Rajya Sabha.



    FDCfixed dose combinationsHansraj Gangaram AhirMinister of State for Chemicals and FertilisersHansraj Gangaram AhirNational Pharmaceutical Pricing AuthorityNPPA
    Source : Inputs from Business Standards

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok